Barrie Kellam - Search Results

Year	Number of Results
2003	3
2004	2
2005	3
2007	2
2010	1
2011	3
2012	2
2013	4
2014	6
2015	4
2016	3
2017	4
2018	8
2019	6
2020	8
2021	5
2022	4
2023	3
2024	4

1

Middleton RJ, Kellam B. Middleton RJ, et al. Among authors: kellam b. Curr Opin Chem Biol. 2005 Oct;9(5):517-25. doi: 10.1016/j.cbpa.2005.08.016. Curr Opin Chem Biol. 2005. PMID: 16125436 Review.

2

Modulators of CXCR4 and CXCR7/ACKR3 Function.

Adlere I, Caspar B, Arimont M, Dekkers S, Visser K, Stuijt J, de Graaf C, Stocks M, Kellam B, Briddon S, Wijtmans M, de Esch I, Hill S, Leurs R. Adlere I, et al. Among authors: kellam b. Mol Pharmacol. 2019 Dec;96(6):737-752. doi: 10.1124/mol.119.117663. Epub 2019 Sep 23. Mol Pharmacol. 2019. PMID: 31548340 Review.

3

Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.

Conroy S, Kindon N, Kellam B, Stocks MJ. Conroy S, et al. Among authors: kellam b. J Med Chem. 2016 Nov 23;59(22):9981-10005. doi: 10.1021/acs.jmedchem.5b01972. Epub 2016 Aug 1. J Med Chem. 2016. PMID: 27413802 Review.

4

Novel selective β₁-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.

Baker JG, Gardiner SM, Woolard J, Fromont C, Jadhav GP, Mistry SN, Thompson KSJ, Kellam B, Hill SJ, Fischer PM. Baker JG, et al. Among authors: kellam b. FASEB J. 2017 Jul;31(7):3150-3166. doi: 10.1096/fj.201601305R. Epub 2017 Apr 11. FASEB J. 2017. PMID: 28400472 Free PMC article.

5

Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2.

Damaskinaki FN, Moran LA, Garcia A, Kellam B, Watson SP. Damaskinaki FN, et al. Among authors: kellam b. Platelets. 2021 Aug 18;32(6):744-752. doi: 10.1080/09537104.2020.1863939. Epub 2021 Jan 7. Platelets. 2021. PMID: 33406951 Review.

6

Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor.

Dekkers S, Caspar B, Goulding J, Kindon ND, Kilpatrick LE, Stoddart LA, Briddon SJ, Kellam B, Hill SJ, Stocks MJ. Dekkers S, et al. Among authors: kellam b. J Med Chem. 2023 Apr 13;66(7):5208-5222. doi: 10.1021/acs.jmedchem.3c00151. Epub 2023 Mar 21. J Med Chem. 2023. PMID: 36944083 Free PMC article.

7

Chemical modification of mammalian cell surfaces.

Kellam B, De Bank PA, Shakesheff KM. Kellam B, et al. Chem Soc Rev. 2003 Nov;32(6):327-37. doi: 10.1039/b211643j. Chem Soc Rev. 2003. PMID: 14671788 Review.

8

The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs.

Vernall AJ, Hill SJ, Kellam B. Vernall AJ, et al. Among authors: kellam b. Br J Pharmacol. 2014 Mar;171(5):1073-84. doi: 10.1111/bph.12265. Br J Pharmacol. 2014. PMID: 23734587 Free PMC article. Review.

9

Fluorescently Labeled Morphine Derivatives for Bioimaging Studies.

Lam R, Gondin AB, Canals M, Kellam B, Briddon SJ, Graham B, Scammells PJ. Lam R, et al. Among authors: kellam b. J Med Chem. 2018 Feb 8;61(3):1316-1329. doi: 10.1021/acs.jmedchem.7b01811. Epub 2018 Jan 10. J Med Chem. 2018. PMID: 29291353

10

Insights into low molecular mass organic gelators: a focus on drug delivery and tissue engineering applications.

Skilling KJ, Citossi F, Bradshaw TD, Ashford M, Kellam B, Marlow M. Skilling KJ, et al. Among authors: kellam b. Soft Matter. 2014 Jan 14;10(2):237-56. doi: 10.1039/c3sm52244j. Soft Matter. 2014. PMID: 24651822 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year